Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-20-000112
Filing Date
2020-02-10
Accepted
2020-02-10 17:17:03
Documents
61
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e1702_10q.htm 10-Q 481332
2 EXHIBIT 10.1 e1702_ex10-1.htm EX-10.1 176302
3 EXHIBIT 31.1 e1702_ex31-1.htm EX-31.1 8102
4 EXHIBIT 31.2 e1702_ex31-2.htm EX-31.2 8194
5 EXHIBIT 32.1 e1702_ex32-1.htm EX-32.1 3950
6 EXHIBIT 32.2 e1702_ex32-2.htm EX-32.2 4056
  Complete submission text file 0001731122-20-000112.txt   3928078

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE enob-20191231.xml EX-101.INS 707370
8 XBRL SCHEMA FILE enob-20191231.xsd EX-101.SCH 37658
9 XBRL CALCULATION FILE enob-20191231_cal.xml EX-101.CAL 52623
10 XBRL DEFINITION FILE enob-20191231_def.xml EX-101.DEF 207902
11 XBRL LABEL FILE enob-20191231_lab.xml EX-101.LAB 309942
12 XBRL PRESENTATION FILE enob-20191231_pre.xml EX-101.PRE 290839
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38758 | Film No.: 20592981
SIC: 2834 Pharmaceutical Preparations